thalidomide has been researched along with tacrolimus in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 12 (50.00) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Burckart, GJ; Eiras, G; Griffith, BP; Hardesty, RL; Keenan, RJ; Stuart, RS; Vogelsang, G; Zeevi, A | 1 |
| McCune, WJ; Singer, NG | 1 |
| Galimberti, M; Gaziev, D; Lucarelli, G; Polchi, P | 1 |
| Myers, SA | 1 |
| Gaziev, D; Lucarelli, G | 1 |
| Sandborn, WJ | 1 |
| Evereklioglu, C | 1 |
| Eisman, S; Orteu, CH | 1 |
| Heath, M; Raugi, GJ | 1 |
| Angelucci, E; Caprilli, R; Cocco, A; Viscido, A; Zippi, M | 1 |
| Kalogirou, O; Kontochristopoulos, G; Panteri, I; Petropoulou, H; Zakopoulou, N | 1 |
| Bolton-Maggs, P; Field, A; Moots, R; Salim, R; Thachil, JV | 1 |
| Koike, H; Oki, Y; Sobue, G | 1 |
| Datta, YH; Ninan, MJ | 1 |
| Georgakopoulou, EA; Scully, C | 1 |
| Kremer, AE; Mettang, T | 1 |
| Liu, T; Qian, G; Zhang, Y; Zhou, C | 1 |
| Bunnapradist, S; Danovitch, G; Huang, E; Lum, EL; Pham, T | 1 |
| Ling, Y; Lu, Y; Su, Z; Sun, W; Xiong, X; Yang, K | 1 |
| Heo, Y; Kim, D; Lee, T; Park, HS; Shin, CS; Yoo, KC | 1 |
14 review(s) available for thalidomide and tacrolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Update on immunosuppressive therapy.
Topics: Adult; Arthritis, Juvenile; Azathioprine; Behcet Syndrome; Child; Cladribine; Cyclophosphamide; Cyclosporine; Drug Therapy, Combination; Granulomatosis with Polyangiitis; Humans; Hydroxychloroquine; Immunosuppressive Agents; Liver; Lung; Lung Injury; Lupus Erythematosus, Systemic; Methotrexate; Pemphigoid, Benign Mucous Membrane; Retina; Tacrolimus; Thalidomide | 1998 |
Chronic graft-versus-host disease: is there an alternative to the conventional treatment?
Topics: Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Photochemotherapy; Tacrolimus; Thalidomide; Transplantation, Homologous; Whole-Body Irradiation | 2000 |
Update on new immunomodulatory agents.
Topics: Adjuvants, Immunologic; Humans; Mycophenolic Acid; Skin Diseases; Tacrolimus; Thalidomide | 2000 |
Novel approaches to the treatment of chronic graft-versus-host disease.
Topics: Chronic Disease; Graft vs Host Disease; Humans; Lymphoid Tissue; Mycophenolic Acid; Photochemotherapy; Tacrolimus; Thalidomide | 2001 |
Transcending conventional therapies: the role of biologic and other novel therapies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antigens, CD; Cell Adhesion Molecules; Clinical Trials as Topic; Crohn Disease; Cytokines; Drugs, Investigational; Etanercept; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunologic Factors; Immunosuppressive Agents; IMP Dehydrogenase; Infliximab; Integrin alpha4; Mycophenolic Acid; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tacrolimus; Thalidomide; Treatment Outcome; Tumor Necrosis Factor-alpha | 2001 |
Managing the symptoms of Behçet's disease.
Topics: Behcet Syndrome; Humans; Interferon-alpha; Tacrolimus; Thalidomide; Tumor Necrosis Factor-alpha; Turkey | 2004 |
Evidence-based evaluation of immunomodulatory therapy for the cutaneous manifestations of lupus.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimalarials; Azathioprine; Cladribine; Cyclophosphamide; Cyclosporine; Evidence-Based Medicine; Humans; Immunoglobulin G; Immunologic Factors; Immunotherapy; Isoxazoles; Leflunomide; Lupus Erythematosus, Cutaneous; Methotrexate; Mycophenolic Acid; Rituximab; Tacrolimus; Thalidomide | 2004 |
Efficacy of conventional immunosuppressive drugs in IBD.
Topics: Azathioprine; Cyclosporine; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Methotrexate; Mycophenolic Acid; Tacrolimus; Thalidomide | 2004 |
Myelodysplastic syndrome with trisomy 8 associated with Behçet syndrome: an immunologic link to a karyotypic abnormality.
Topics: Adolescent; Anemia, Refractory; Behcet Syndrome; Chromosomes, Human, Pair 8; Female; Humans; Immunologic Deficiency Syndromes; Immunosuppressive Agents; Karyotyping; Oral Ulcer; Tacrolimus; Thalidomide; Trisomy | 2008 |
[Adverse effects of therapeutic drugs on peripheral nervous system].
Topics: Anti-HIV Agents; Anticonvulsants; Antineoplastic Agents; Antitubercular Agents; Cisplatin; Dose-Response Relationship, Drug; Early Diagnosis; Humans; Immunosuppressive Agents; Paclitaxel; Peripheral Nervous System Diseases; Phenytoin; Tacrolimus; Thalidomide; Vincristine | 2007 |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Diabetic Nephropathies; Disease Progression; Epstein-Barr Virus Infections; Fatal Outcome; Ganciclovir; Humans; Immunosuppressive Agents; Kidney Transplantation; Lumbar Vertebrae; Lymphoproliferative Disorders; Male; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Pancreas Transplantation; Plasmacytoma; Postoperative Complications; Prednisone; Reoperation; Rituximab; Spinal Neoplasms; Tacrolimus; Thalidomide | 2010 |
Systemic use of non-biologic agents in orofacial diseases: other immunomodulatory agents.
Topics: Anti-Infective Agents; Calcineurin Inhibitors; Colchicine; Cyclophosphamide; Cyclosporine; Dapsone; Drug Interactions; Drug Monitoring; Facial Dermatoses; Humans; Immunosuppressive Agents; Mouth Diseases; Tacrolimus; Thalidomide; Tubulin Modulators | 2015 |
Uremic pruritus.
Topics: Acupuncture Therapy; Amines; Anti-Inflammatory Agents; Calcium Channel Blockers; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; gamma-Linolenic Acid; Humans; Morphinans; Naltrexone; Narcotic Antagonists; Pentoxifylline; Phototherapy; Pregabalin; Pruritus; Receptors, Opioid, kappa; Renal Insufficiency, Chronic; Spiro Compounds; Tacrolimus; Thalidomide; Uremia | 2015 |
10 other study(ies) available for thalidomide and tacrolimus
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506.
Topics: Calcimycin; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Drug Interactions; Humans; Immune Tolerance; In Vitro Techniques; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Phytohemagglutinins; Tacrolimus; Thalidomide | 1991 |
Recalcitrant erosive flexural lichen planus: successful treatment with a combination of thalidomide and 0.1% tacrolimus ointment.
Topics: Aged; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lichen Planus; Tacrolimus; Thalidomide | 2004 |
Effective treatment of erosive lichen planus with thalidomide and topical tacrolimus.
Topics: Administration, Topical; Humans; Immunosuppressive Agents; Lichen Planus; Lichen Planus, Oral; Male; Middle Aged; Penile Diseases; Tacrolimus; Thalidomide | 2006 |
Successful treatment of recalcitrant granulomatous rosacea with oral thalidomide and topical pimecrolimus.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Retreatment; Rosacea; Tacrolimus; Thalidomide | 2015 |
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma.
Topics: Adrenal Cortex Hormones; Aged; Antilymphocyte Serum; Deprescriptions; Female; Graft Rejection; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Kidney; Kidney Transplantation; Lenalidomide; Maintenance Chemotherapy; Multiple Myeloma; Mycophenolic Acid; Polycystic Kidney, Autosomal Dominant; Tacrolimus; Thalidomide | 2017 |
Case of sarcoidosis presenting with symmetrical facial keratotic papules.
Topics: Cheek; Female; Hepatic Duct, Common; Humans; Keratosis; Lymph Nodes; Lymphadenopathy; Middle Aged; Sarcoidosis; Skin; Tacrolimus; Thalidomide; Tomography, X-Ray Computed | 2018 |
Successful Treatment of Life-Threatening Small Bowel Bleeding With Thalidomide After Living Donor Kidney Transplantation: A Case Report.
Topics: Aged; Angiogenesis Inhibitors; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Melena; Middle Aged; Postoperative Complications; Tacrolimus; Thalidomide | 2019 |